Zobrazeno 1 - 10
of 101
pro vyhledávání: '"Kristin M, Sheffield"'
Autor:
Alistair Ring, Meghan Karuturi, Emily Nash Smyth, Tasneem Lokhandwala, Kristin M. Sheffield, Joanne Willey, Orsolya Lunacsek, Francisco Sapunar, Zhanglin Lin Cui, Anna D. Coutinho, Sarah Rybowski
Publikováno v:
Drugs - Real World Outcomes, Vol 10, Iss 4, Pp 589-603 (2023)
Abstract Introduction Hormone receptor-positive (HR+)/human epidermal growth factor receptor 2-negative (HER2−) is the most frequently diagnosed metastatic breast cancer (mBC) subtype. Combinations of endocrine therapy (ET) with cyclin-dependent ki
Externí odkaz:
https://doaj.org/article/aa1788c9bb694e03a3c95d560933648e
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 12, Iss 2 (2023)
Aim: This real-world study aims to compare overall survival (OS) associated with biweekly (Q2W) versus weekly (Q1W) cetuximab dosing regimens for metastatic colorectal cancer (mCRC) treatment in the US. Methods: Adult patients with KRAS wild-type m
Externí odkaz:
https://doaj.org/article/3d3a14ada5a24baf94879848d762bf5d
Autor:
Alistair Ring, Meghan Karuturi, Emily Nash Smyth, Tasneem Lokhandwala, Kristin M. Sheffield, Joanne Willey, Orsolya Lunacsek, Francisco Sapunar, Zhanglin Lin Cui, Anna Coutinho, Sarah Rybowski
Publikováno v:
Advances in Therapy. 40:2515-2523
Autor:
Julie Beyrer, David R Nelson, Kristin M Sheffield, Yu-Jing Huang, Yiu-Keung Lau, Ana L Hincapie
Publikováno v:
Clinical Epidemiology. 15:73-89
Julie Beyrer,1,* David R Nelson,1,* Kristin M Sheffield,1,* Yu-Jing Huang,1,* Yiu-Keung Lau,1,* Ana L Hincapie2,* 1Eli Lilly and Company, Indianapolis, IN, USA; 2University of Cincinnati James L. Winkle College of Pharmacy, Ci
Autor:
Rebecca Ellen Goulding, Matthew Chenoweth, Gebra Cuyun Carter, Mark Ernest Boye, Kristin M Sheffield, William J John, Mark Steven Leusch, Catherine Elizabeth Muehlenbein, Li Li, Min-Hua Jen, Adina Rojubally, Jeroen Jansen, Eric Druyts
Publikováno v:
Cancer Treatment and Research Communications, Vol 24, Iss , Pp 100200- (2020)
KRAS (Kirsten Rat Sarcoma) is the most common oncogenic mutation detected in patients with non-small cell lung cancer (NSCLC). However, the role of KRAS as either a prognostic factor or predictive factor (modifier of treatment effects) in NSCLC is no
Externí odkaz:
https://doaj.org/article/8d4a2489397e4e478a6287ecb9ffb2ec
Publikováno v:
Statistics in Biosciences. 14:259-284
Autor:
Josephine Feliciano, Katherine B. Winfree, Zhanglin Lin Cui, Kristin M Sheffield, Tomoko Sugihara
Publikováno v:
Current Medical Research and Opinion. 38:91-99
This retrospective, observational study examined patient characteristics, treatment patterns, testing patterns, and outcomes of US patients receiving first-/second- or third-generation epidermal gr...
Autor:
Yajun Emily Zhu, Yu-Jing Huang, Andrew D. Seidman, Claudia Morato Guimaraes, Gebra Cuyun Carter, Kristin M Sheffield, Anala Gossai, Erik Rasmussen, Shreya Balakrishna, Emily Nash Smyth, Sarah Rybowski, Aaron B Cohen, Raina Mathur, Lee Bowman
Publikováno v:
Current Medical Research and Opinion. 37:1179-1187
This retrospective observational study described baseline characteristics, real-world treatment patterns, and outcomes among patients with metastatic breast cancer treated with abemaciclib in the United States.De-identified electronic health record-d
Autor:
Kristin M Sheffield, Jessica R Peachey, Michael Method, Brenda R Grimes, Jacqueline Brown, Kim Saverno, Tomoko Sugihara, Zhanglin Lin Cui, Kimberley T Lee
Publikováno v:
Future oncology (London, England). 18(21)
Aim: To assess invasive disease-free survival (IDFS) and distant relapse-free survival (DRFS) in hormone receptor-positive, HER2-negative early breast cancer with combined clinicopathological criteria from monarchE, a phase III study of abemaciclib.
Autor:
Paula D. Ryan, Yu-Jing Huang, Kristin M Sheffield, Gebra Cuyun Carter, Jonathan Rajkumar, Lavanya Sudharshan, Gregory L Price, Claudia Morato Guimaraes, Emily Nash Smyth, Sarah Rybowski
Publikováno v:
Journal of the National Comprehensive Cancer Network. 19:HSR21-051